Skip to main content
Premium Trial:

Request an Annual Quote

Merck Licenses Deltagen Gene Function Database

NEW YORK, Feb. 11—Deltagen has licensed its mammalian gene function database to Merck, the company said in a statement today.

By the terms of the deal, Merck has non-exclusive access to functional data from 750 genes and some associated intellectual property rights. 

Deltagen’s DeltaBase organizes  in vivo mammalian gene function information derived from large-scale mouse knockout studies. The database connects phenotypic information from these studies with expression profile data to clarify gene interrelationships and biochemical pathways. 

Other database subscribers include Lexicon, GlaxoSmithKline, Pfizer and Vertex.

Financial details of this deal were not disclosed. In 2000, DeltaBase charged Pfizer $15 million for a three-year subscription. 

Redwood City, Calif.-based Deltagen is publicly owned. The company also is working on a database that will use mouse knockouts to collect gene expression profiles in a range of tissues.  
The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.